POPULARITY
Categories
"The thought of recurrence is also a psychosocial issue for our patients. They're being monitored very closely for five years, so there's always that thought in the back of their head, 'What if the cancer comes back? What are the next steps? What am I going to do next?' It's really important that we have conversations with patients and their families about where they're at, what we're looking for, and reassure them that we'll be with them during this journey and help them through whatever next steps happen," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer survivorship considerations for nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by December 19, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to survivorship nursing considerations for people with prostate cancer. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 390: Prostate Cancer Treatment Considerations for Nurses Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: APRNs Collaborate With PCPs on Shared Survivorship Care Models Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors Nursing Considerations for Prostate Cancer Survivorship Care Regular Physical Activity and Healthy Diet Lower Risk of All-Cause and Cardiac Mortality in Prostate Cancer Survivors Sexual Considerations for Patients With Cancer Sleep Disturbance Is Part of a Behavioral Symptom Cluster in Prostate Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing articles: A Patient-Specific, Goal-Oriented Exercise Algorithm for Men Receiving Androgen Deprivation Therapy Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Prostate Cancer: Survivorship Care Case Study, Care Plan, and Commentaries The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: A Qualitative Exploration of Prostate Cancer Survivors Experiencing Psychological Distress: Loss of Self, Function, Connection, and Control Identification of Symptom Profiles in Prostate Cancer Survivors Sleep Hygiene Education, ReadiWatch™ Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia for People With Prostate Cancer Understanding Men's Experiences With Prostate Cancer Stigma: A Qualitative Study Other ONS resources: Late Effects of Cancer Treatment Huddle Card Survivorship Care Plan Huddle Card Survivorship Learning Library American Cancer Society (ACS): Living as a Prostate Cancer Survivor ACS prostate cancer survivorship studies To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the most common late side effects [are] urinary, bowel, and sexual dysfunction issues. For urinary effects, it can include urgency and frequency, some incontinence, or a weak or slow urine stream that frequently bothers the patient after treatment. Bowel effects can happen such as constipation, diarrhea, or inflammation of the rectum, which can lead to bleeding or mucus discharge. And then erectile dysfunction is another side effect that patients with prostate cancer often deal with and have to work with their physicians on, depending on what they want with that function. Fatigue, lymphedema, and skin changes can also occur after treatment." TS 1:40 "If we can catch [prostate cancer] and take care of it at an early stage, overall survival is about 90%. If the disease is localized, it's 99%. If we can take out the prostate, radiate the prostate, we can do something with that—localized, 99% survival rate. If there's regional metastasis, it's about 90%. And if there's distant metastasis, it's about 30% survival." TS 3:55 "Prostate cancer recurs in about 20%–30% of patients within the first five years of initial treatment. ... There's not a lot of research out there that shows what can reduce risk, but what has been shown to be effective is regular exercise, quitting smoking, and eating a healthy diet. ... It's really important for our patients to understand the importance of having follow-up visits so that we can catch a recurrence quickly instead of waiting years down the road. Prostate cancer is usually a slow-growing disease, so if we can pick it up quickly in those revisits, we can start another treatment for the patient." TS 6:00 "Sexuality is not something many people are comfortable discussing, but we really need to talk with patients and let them know that this is normal. It is normal that you may have some sexual dysfunction. It's normal that you may not feel the way you did before. Talk to us about it, let us know where you're at, let us know what your goals are, because there are a lot of things we can do. There are medications we can use for impedance. There are devices and implants available to help the patient to support them and give them whatever their goal is for their sexuality." TS 9:41 "Providing survivorship care plans are important for these patients—something that can be sent off to everyone else that's caring for that patient. You have your primary care physician, urologist, oncologist, the oncology nurse, maybe a navigator, and [others] who are looking into this patient. So, giving that patient a survivor care plan and putting it with their files to include a summary of the treatment received, because most of the time a patient is not going to remember exactly what they received. A suggested schedule for follow-up exams—so again, if a primary care provider is not used to dealing with a patient with prostate cancer, they have something to go off of. A schedule of other tests they may need in the future including screening for other types of cancer. Are they a smoker? Do they need lung screening? Do they need any other screenings related to types of cancers? And then a list of possible late or long-term side effects." TS 15:16 "I think a lot of people know about the long-term sexual effects, but what we don't really talk about is the effect that it has on the patient's self-image. How they define themselves, how they look, their body image, their self-image. It's really important that we continue to discuss it with patients and make them comfortable when discussing their sexuality and their goals for sexuality. They may be having these self-image issues after treatment that they're just not telling us about and that can affect their quality of life." TS 18:38
Welcome to episode 310 of Grow Your Law Firm, hosted by Ken Hardison. In this episode, Ken is joined by Jake Soffer, Founder and CEO of FirmPilot, an AI-driven marketing platform built to help law firms acquire more clients through intelligent automation and deep market data. Jake brings over a decade of experience in natural language processing and artificial intelligence, rooted in his computer engineering studies at RPI and NYU. Before founding FirmPilot, he built and exited companies in the NLP space and now leads one of the most advanced AI marketing systems in the legal industry—what he calls a "high-performing AI agency in a box." With FirmPilot now supporting more than 120 firms, Jake is at the forefront of how AI, competitive intelligence, and real-time data are reshaping the way legal practices grow. What you'll learn about in this episode: 1. How AI Content Really Works - What differentiates low-quality AI content from high-performing - Why models trained on legal sources outperform generic tools like ChatGPT 2. Using Market Data to Outperform Competitors - Why copying what you see your competitors doing will usually fail - How to analyze deeper signals like backlinks, markup, and behavioral data 3. Domain Authority and Backlinks - What domain authority really measures and how to interpret it - Why quality, consistency, and relevance in link building now outweigh volume 4. Attribution and Tracking in a Multi-Channel World - Why last-touch attribution no longer gives you the full picture - How Google Tag Manager and call-tracking create accurate marketing feedback loops 5. Preparing for the Future of AI Search - How generative engines like ChatGPT and Gemini evaluate legal expertise - Why optimizing for "fanned-out queries" and AI overviews is becoming essential Resources: Website: firmpilot.com LinkedIn: linkedin.com/in/jake-soffer-jd-00797a62 Facebook: facebook.com/p/FirmPilot-100092301576461 Instagram: instagram.com/firmpilot Additional Resources: https://www.pilmma.org/the-mastermind-effect https://www.pilmma.org/resources https://www.pilmma.org/mastermind AI for PI Expo: www.pilmma.org/ai-for-pi-expo
Measuring marketing's impact is hard. There's no silver bullet. And if someone tells you there is, they're probably selling you something that only tracks clicks.This week, Elena, Angela, and Rob are joined by Chief Analytics Officer Matt Hultgren to tackle one of marketing's most persistent challenges: measurement. They explore why so many campaigns fail before they even launch, how to balance short-term performance with long-term brand building, and why the best marketers use multiple models to find the truth.Topics covered: [02:00] Why human behavior makes measurement messy[04:00] The planning problem causing measurement failures[06:00] Choosing your North Star metric[08:00] Balancing immediate CAC with long-term brand growth[10:00] Using multiple models to triangulate the truth[13:00] Quantifying TV's halo effect across channels[15:00] Incrementality testing vs MMM vs synthetic controls To learn more, visit marketingarchitects.com/podcast or subscribe to our newsletter at marketingarchitects.com/newsletter. Resources: 2025 Marketing Architects Report: https://www.marketingarchitects.com/Long-and-Short Get more research-backed marketing strategies by subscribing to The Marketing Architects on Apple Podcasts, Spotify, or wherever you listen to podcasts.
It's an episode just absolutely full of fish! Thanks to Arthur, Yuzu, Jayson, Kabir, Nora, Siya, Joel, Elizabeth, Mac, Ryder, Alyx, Dean, and Riley for their suggestions this week! Further reading: Study uncovers mechanics of machete-like 'tail-whipping' in thresher sharks Business end of a sawfish: Giant freshwater stingray! The frilled shark looks like an eel: The frilled shark's teeth: The thresher shark and its whip-like tail [photo by Thomas Alexander - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=50280277]: The Halmahera epaulette shark, looking a little bit like a long skinny koi fish [photo by Mark Erdmann, California Academy of Sciences, Attribution, https://commons.wikimedia.org/w/index.php?curid=30260864]: A mudskipper, which is a fish even though it kind of looks like a weird frog [photo by Heinonlein - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=44502355]: The red-lipped batfish wants a big kiss: The male blue groper is very blue [photo by Andrew Harvey, some rights reserved (CC BY) - https://www.inaturalist.org/photos/62196538, CC BY 4.0, https://commons.wikimedia.org/w/index.php?curid=157789928]: The giant oarfish is very long: Show transcript: Welcome to Strange Animals Podcast. I'm your host, Kate Shaw. This week we have a big fish episode! I mean, it's a big episode about a lot of different fish, not necessarily fish that are big—although some of them sure are! Thanks to Arthur, Yuzu, Jayson, Kabir, Nora, Siya, Joel, Elizabeth, Mac, Ryder, Alyx, Dean, and Riley. I told you this is a big fish episode. Let's jump right in with a fish suggested by Jayson, the sawfish. There are five species of sawfish alive today. The smallest can still grow over 10 feet long, or 3 meters, while the biggest species can grow over 20 feet long, or 6 meters. The largest sawfish ever reliably measured was 24 feet long, or 7.3 meters. The sawfish lives mostly in warm, shallow ocean waters, usually where the bottom is muddy or sandy. It can also tolerate brackish and even freshwater, and will sometimes swim into rivers and live there just fine. The sawfish is a type of ray, and rays are most closely related to sharks. Like sharks, rays have an internal skeleton made of cartilage instead of bone, but they also have bony teeth. You can definitely see the similarity between sharks and sawfish in the body shape, although the sawfish is flattened underneath, which allows it to lie on the ocean floor. There's also another detail that helps you tell a sawfish from most sharks: the rostrum, or snout. It's surprisingly long and studded with teeth on both sides, which makes it look like a saw. The teeth on the sawfish's saw are actual teeth. They're called rostral teeth and the rostrum itself is part of the skull, not a beak or a mouth. It's covered in skin just like the rest of the body. The sawfish's mouth is located underneath the body quite a bit back from the rostrum's base, and the mouth contains a lot of ordinary teeth that aren't very sharp. Since the sawfish has plenty of teeth in its mouth, you may be wondering how and why it also has extra teeth on both sides of its saw. It's because the rostral teeth evolved from dermal denticles. Dermal denticles look like scales but they're literally teeth, they're just not used for eating. Sharks have them too, along with some other fish. In the case of the sawfish, the rostral teeth grow much larger than an ordinary dermal denticle, and stick out sideways. Both the rostrum and the head are packed with electroreceptors that allow the sawfish to sense tiny electrical charges that animals emit as they move. This might mean a school of fish swimming through muddy water, or it might mean a crustacean hiding in the sand. The sawfish sometimes uses its rostrum to dig prey out of the sand, but it also uses it to slash at fish or other animals.
The party wraps up its investigation of Greengripe and makes a controversial deal with an enemy. Meanwhile, Mike needs a recon.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text
Episode Notes Even though Jesus would be found in an animal stall the sign they were given was so blatant that they could not miss Jesus when they saw Him. They would know for sure, despite any heavenly sign or imparted Godly knowledge to them, that this babe in swaddling clothes was undeniably Jesus Christ, known also as the Son of God and the Son of Man because of His unique birth. Our Outreach Web site is now closed. Sorry for any inconvenience. Introduction ~ About Us, Who We Are: Episode 1 How-To Be Saved: Episode 2 **** “End Times” and “Benediction” A “Barking Squirrel Production” Copyright: 2018 ~ All Rights Reserved Our Series: “Christmas 2025”: 2025-1202 Episode: 49 Copyright: 2025 TAGS: #Gospel #Christ #Newbirth #Joy #Holiness ---------------------------------------------- The following music was used for this media project: Music: Silent Night - Holy Night by Alexander Nakarada License (CC BY 4.0): https://filmmusic.io/standard-license Artist website: https://www.serpentsoundstudios.com/ Modified by: Pastor John Music: Jingle Jangle Bells by Snoozy Beats License (CC BY 4.0): licensed under a Attribution 4.0 International License. Allowed usage for Personal and commercial use. This music track (or part of it) was generated by A.I. The full track can be heard here: https://freemusicarchive.org/music/snoozy-beats/single/jingle-bells-kinda-day-10/ Edited by: Pastor John This podcast is powered by Pinecast.
In dieser Folge sprechen wir mit Birger Schäfermeier, dem CEO der tradAc (European Trading Academy AG) und Geschäftsführer von Arete Trading, über Trading, Mindset und persönliche Freiheit. Wir gehen der Frage nach, warum so wenige Menschen wirklich profitabel handeln und welche tief verankerten Glaubenssätze viele Deutsche dabei ausbremsen. Birger teilt seine Sicht darauf, was Freiheit eigentlich bedeutet, warum Emotionen beim Traden oft unterschätzt werden – und ob es überhaupt „negative“ Emotionen gibt. Zum Abschluss reden wir über ein Thema, das jeden beschäftigt: Macht Geld wirklich glücklich?
A wealthy British businessman living in colonial Egypt finds his comfortable life begin to unravel when he is haunted by the mysterious sound of footsteps that seem to follow him through the streets at night.This original recording is an audio presentation by Jasper L'Estrange for EnCrypted Horror. “THE STEP” by E.F. Benson, 1931.Supporting my workIf you like, you can donate in the following ways:Patreon: https://www.patreon.com/encryptedpodYouTube channel membership: https://www.youtube.com/c/EnCryptedClassicHorror/joinOne-off donation: https://ko-fi.com/encryptedpodcastYou can now also say THANKS (on YouTube) with a SUPER THANKS!LIKE, COMMENT, SHARE - it all helps the show survive and prosper!If you want to discuss the show, talk business, or have any ideas for stories you'd like to hear in future episodes, contact me: encryptedpod@gmail.com
"I'll go back to the backpack analogy. When your kids come home with a backpack, all of a sudden their homework is not on the desk where it's supposed to be. It's in the kitchen; it kind of spreads all over the place, but it's still in the house. When we give antibody–drug conjugates (ADCs), the chemotherapy does go in, but then it can kind of permeate out of the cell membrane and something right next to it—another cancer cell that might not look exactly like the cancer cell that the chemotherapy was delivered into—is affected and the chemotherapy goes over to that cancer cell and kills it," ONS member Marisha Pasteris, OCN®, office practice nurse in the breast medicine service at Memorial Sloan Kettering Cancer Center in New York, NY, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about ADCs in metastatic breast cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 This podcast is sponsored by Gilead and is not eligible for NCPD contact hours. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: Episode 391: Pharmacology 101: Antibody–Drug Conjugates Episode 378: Considerations for Adolescent and Young Adult Patients With Metastatic Breast Cancer Episode 368: Best Practices for Challenging Patient Conversations in Metastatic Breast Cancer Episode 350: Breast Cancer Treatment Considerations for Nurses Episode 303: Cancer Symptom Management Basics: Ocular Toxicities ONS Voice articles: An Oncology Nurse's Guide to Cancer-Related Ocular Toxicities Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options Communication Case Study: Talking to Patients About Progressive Metastatic Breast Cancer What Is HER2-Low Breast Cancer? ONS Voice drug reference sheets: Belantamab mafodotin-blmf Datopotamab deruxtecan-dlnk Enfortumab vedotin-ejfv Fam-trastuzumab deruxtecan-nxki ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Guide to Breast Care for Oncology Nurses Guide to Cancer Immunotherapy (second edition) ONS courses: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ ONS/ONCC® Chemotherapy Immunotherapy Certificate™ Clinical Journal of Oncology Nursing article: Antibody–Drug Conjugates and Ocular Toxicity: Nursing, Patient, and Organizational Implications for Care The Association Between Hormone Receptor Status and End-of-Life Care Among Patients With Metastatic Breast Cancer Oncology Nursing Forum article: Impact of Race and Area Deprivation on Triple-Negative Metastatic Breast Cancer Outcomes ONS huddle cards: Altered Body Image Huddle Card Chemotherapy Huddle Card Targeted Therapy Huddle Card Foundations of Antibody–Drug Conjugate Use in Metastatic Breast Cancer: A Case Study ONS Biomarker Database (refine by breast cancer) ONS Breast Cancer Learning Library American Society of Clinical Oncology (ASCO) homepage Drugs@FDA package inserts National Comprehensive Cancer Network homepage Susan G. Komen metastatic breast cancer page To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "What an ADC is doing is taking the antibody and linking it to a cytotoxic chemotherapy with the idea of delivering it directly into the cell. How I explain this to new nurses or patients is a backpack analogy. If we think of it as a HER2 molecule wearing a chemo backpack, it's going to find the HER2 receptor attached to it and then drop the chemotherapy into the cell via the backpack. Similar to how we come home from work, we open the key to our door, we're carrying all of our items, and then we drop our own personal items in our house." TS 2:30 "The reason that so many patients with metastatic breast cancer are able to receive ADC therapy is because they are targeting two very common antibodies that we see in breast cancer. One is HER2 and the other is trophoblast cell surface antigen 2 (TROP2). These are seen across the board. We see these on triple-negative breast cancers, hormone receptor–positive cancers, and HER2-positive breast cancers. And now we have a new way to talk about HER2, which is a HER2-low. ... Recently, we have found that patients who express low levels of HER2 are able to receive ADC therapy, specifically fam-trastuzumab deruxtecan." TS 4:21 "Another [ADC] that has just been approved is datopotamab deruxtecan. This is another ADC that targets the TROP2 receptor on a cancer cell. This one carries a lot of side effects. I mentioned earlier that you need an ophthalmology clearance because there is a lot of ocular toxicity around this one. We see a lot of blepharitis, conjunctivitis, there can be blurred vision. Another thing we monitor on this one is mucositis. In the package insert, there's a recommendation for using ice chips while receiving the treatment. ... Then in the HER2-positive and HER2-low space is the big one, which is fam-trastuzumab deruxtecan. This was approved in 2019 for the HER2-positive patients, then more recently in the HER2-low [patients]. The big [side effect] with this one is interstitial lung disease." TS 10:11 "Interstitial lung disease is an inflammation or a little bit of fibrosis within the lung that causes an impaired exchange between the oxygen and carbon dioxide. This was seen in the clinical trials, specifically around fam-trastuzumab deruxtecan. During the trials, they had a very small percentage, I think it was 1%, that died due to interstitial lung disease. So, this is a very important side effect for us as nurses to be aware of. It typically presents in patients like a dyspnea. A lot of times, it's like, 'Well, I used to be able to walk my kid to the bus stop, but now when I walk there, I feel really short of breath.' Or 'I've had this dry cough for the past couple weeks and I've tried medications, but haven't had that relieved.' So, we really need to be aware of that because early intervention in interstitial lung disease is key." TS 12:57 "ADCs are toxic drugs. They have the benefit of being targeted, but we know that they carry a lot of side effects. ... Their specificity makes them so wonderful and we've seen amazing responses to these drugs. But also, we want patients to be safe. We want to give these drugs safely. So, we have to assess our patients and make sure that this is an appropriate patient to give this therapy to. I think that's an open conversation that clinicians need to have with patients regarding these drugs." TS 18:08
Of Monsters and Mushrooms, Ch. 12 (book 1 NEW) ep. 809 The Literal Boulder from Indiana Jones NOTE: This is a rewrite of book 1. Originally, 'Of Monsters and Mushrooms' was supposed to be a multi-part short story that transformed halfway through into a novel. This left the plot (and the voice acting, to be honest) lacking. We decided to go back and completely rewrite book one to fix any plot holes and bring the quality in line with the rest of the series. Listen to the new book one playlist here https://talltaletv.com/series-of-monsters-and-mushrooms-new/ or Listen to book one (NEW!) https://talltaletv.com/series-of-monsters-and-mushrooms-new/ Listen to book two http://talltaletv.com/series-of-tyrants-and-teakettles/ Listen to book three http://talltaletv.com/series-of-bandits-and-bad-magic/ Listen to book 3.5 https://talltaletv.com/series-an-interlude-of-intrigue/ Listen to book four https://talltaletv.com/series-of-portals-and-portents/ Listen to book five https://talltaletv.com/series-of-risk-and-relativity/ Listen to the original book one http://talltaletv.com/series-monsters-mushrooms/ ---- Listen Elsewhere ---- YouTube: https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you! ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords
Episode 20- The Unborn has arrived. Fight fight fight! An actual play, tabletop role-playing game that uses the Pathfinder 1E rule-set. The epic story follows the brave players through a unique dark fantasy world. The Heroes trials and tribulations will have them brought face to face with demons, devils, angry spirits, the occult, and more. The story takes place in the dark fantasy world of Mel'Herron. Our heroes are brought together by mysterious circumstances leaving them with more questions than answers. An ever-present dark force seems to be lurking in the shadows seeking the party for reasons they must figure out or be swept up by the coming storm. Please like and follow !!! =) Marty is the Dungeon Master, Bobby plays Uri, Wes plays Rein, Derek plays Solaris, Morris play Lirium, Marcus plays Torad Follow us on Twitter: @dicebargaming1 Facebook: The Dice Bar Gaming Podcast Music by: https://www.fesliyanstudios.com Scott Buckley www.scottbuckley.com.au. Kevin MacLeod Link: https://incompetech.filmmusic.io/song/5048-stay-the-course License: https://filmmusic.io/standard-license. Paid license from: www.epidemicsound.com March of Midnight by Scott Buckley | www.scottbuckley.com.au Music promoted by https://www.chosic.com Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/ Unseen Horrors Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/ Music promoted by https://www.chosic.com/ For world info- https://www.worldanvil.com/w/mel-herron-bruehawk Friends of the podcast: Bored Online? Board Offline!- https://www.youtube.com/channel/UCVmlVsZVlruYWnIYd42iBhw Game Knight Hero Podcast- https://podcasts.apple.com/us/podcast/game-knight-heroes/id1552887060 Deadlands by Kerri Smith- https://www.youtube.com/channel/UCAVrPUutK3IvxLWDKaN3UgQ **Episodes contain adult content. “a mature Podcast”**
Natalia Chappell is the founder of Natalia Chappell & Co, a UK-based consultancy helping luxury and lifestyle brands scale sustainably. Previously, she led marketing for THG's luxury division, working with brands like Coach and Ralph Lauren across price points from hundreds to thousands of pounds.In this episode of DTC Pod, Natalia breaks down what it really takes for US brands to win in the UK—and why so many get it wrong. She shares the full-funnel mistakes she sees premium brands make over and over, why some household US names thrived in Britain while others quietly retreated, and what's actually driving results on Meta right now. She also gets into how to connect with younger consumers who think differently about spending, and why the old playbook of polished content isn't cutting it anymore. Plus, her journey from corporate marketing leader to female founder, and what she wishes more people understood about building a business as a woman.Episode brought to you by StordInteract with other DTC experts and access our monthly fireside chats with industry leaders on DTC Pod Slack.On this episode of DTC Pod, we cover:1. Lessons from high-growth UK e-commerce brands 2. Creating sustainable, holistic marketing strategies3. Using data and analytics to drive channel mix decisions4. Optimizing for paid and organic synergy5. Landing page and website audit best practices6. UGC, influencer, and creator partnership frameworks7. Onboarding and managing creators for conversion and brand fit8. Navigating UK logistics, customs, and local expectations9. How to adapt brand voice and content for UK consumer10. UK cultural moments and how to plan campaigns around them11. Success stories (Drunk Elephant, Ralph Lauren, Coach) and why some US brands flop12. Digital-first approaches to brand building13. Upcoming trends—partnership ads, authentic content, and Gen Z consumers14. Supporting and growing as a female founder in e-commerceTimestamps00:00 Introduction to DTC POD and episode with Natalia Chappell01:18 Natalia's background: fashion, digital marketing, luxury brand experience03:26 Lessons learned building luxury and beauty e-commerce teams05:16 Becoming a female founder and launching Natalia Chappell & Co07:22 The type and scale of brands Natalia's agency works with09:07 Optimizing paid-to-organic mix for sustainable growth12:12 Data, analytics, and the importance of first-party data integrity13:33 Why understanding inventory and offer depth matters before scaling ads16:26 Building a marketing flywheel that feeds itself18:50 Audience segmentation, CRM, and conversion optimization20:08 Attribution modeling and keeping data integrations clean22:29 Organic growth: auditing website, SEO, landing pages, and reviews24:03 Content strategy: authentic UGC, influencers, and the UK market26:58 Equipping creators for conversion, not just reach29:25 Structuring affiliate and creator programs, commissioning vs. flat fees33:01 Logistics: Warehousing, customs, and UK delivery expectations36:54 Adapting voice, copy, and calendar to resonate in the UK38:34 Brand case studies: Drunk Elephant, Coach, Ralph Lauren41:09 Why some US brands struggle in the UK (Forever 21, etc.)44:21 Trends to watch: partnership ads, content authenticity, Gen Z targeting47:25 Where to find and connect with Natalia ChappellShow notes powered by CastmagicPast guests & brands on DTC Pod include Gilt, PopSugar, Glossier, MadeIN, Prose, Bala, P.volve, Ritual, Bite, Oura, Levels, General Mills, Mid Day Squares, Prose, Arrae, Olipop, Ghia, Rosaluna, Form, Uncle Studios & many more. Additional episodes you might like:• #175 Ariel Vaisbort - How OLIPOP Runs Influencer, Community, & Affiliate Growth• #184 Jake Karls, Midday Squares - Turning Your Brand Into The Influencer With Content• #205 Kasey Stewart: Suckerz- - Powering Your Launch With 300 Million Organic Views• #219 JT Barnett: The TikTok Masterclass For Brands• #223 Lauren Kleinman: The PR & Affiliate Marketing Playbook• #243 Kian Golzari - Source & Develop Products Like The World's Best Brands-----Have any questions about the show or topics you'd like us to explore further?Shoot us a DM; we'd love to hear from you.Want the weekly TL;DR of tips delivered to your mailbox?Check out our newsletter here.Projects the DTC Pod team is working on:DTCetc - all our favorite brands on the internetOlivea - the extra virgin olive oil & hydroxytyrosol supplementCastmagic - AI Workspace for ContentFollow us for content, clips, giveaways, & updates!DTCPod InstagramDTCPod TwitterDTCPod TikTokNatalia Chappell - Founder of Natalia Chappell & Co.Blaine Bolus - Co-Founder of CastmagicRamon Berrios - Co-Founder of Castmagic
Welcome to another edition of #BettinNBoozin on the HHH Racing Podcast! This episode we stay in South Florida for Ep 159 to preview the Late Pick5 at Gulfstream Park for the Tropical Park Oaks and Derby card brought to you by TwinSpires! Who do we think wins? Find out in this episode!Come for the handicapping, stay for a drink!It's a great day to make some money, we are always Boozin N Not Losin! Stay tuned for GREAT ANALYSIS and see you in the LIVE CHAT!Please Like, Subscribe and comment below the video player your opinions, we would love to hear from you and respond to every one!__________________________________________________________________NORMAL PODCAST SCHEDULE:Tuesday Night @9:30pm EDT: Pacific Horseplayers with Noah, Ryan and JacksonWednesday Night @8pm EDT: Bettin N Boozin with Kyle, Patrick and Charlie (Noah) Thursday Night @8pm EDT: Picks and Ponies with Howard, Pete and Paul(MORE COULD BE ADDED AT ANY TIME, PLEASE SUBSCRIBE AND HIT THE NOTIFICATION BELL TO BE NOTIFIED OF ALL LIVESTREAMS/VIDEOS!)__________________________________________________________________Go to our website: https://www.hhhracingpodcast.com__________________________________________________________________Podcast Twitter/X: @hhhracingpodHost:Kyle Roscoe: X - @APRoscoeKCo-Hosts:Andrew Rdesinski: X - @phillyboy415Patrick Kuenzel: X - @PatrickKuenzelCharlie Freeman: X - @CFREE316_________________________________________________________________Horse Racing Promotions: Subscribe to the excellent, informative, AFFORDABLE and profitable "Power Picks" Tip Sheet! Please go to: www.patreon.com/hhhracingpodcast Fantastic ABC P4 and P5 grids, along with Spot Plays and Price Plays provided that currently has an ROI around $2.15 (national average is $1.60). Picks arrive via email every Sat. morning for that day's races. Purchase your Power Picks NOW and make 2024 your best handicapping year ever! www.patreon.com/hhhracingpodcast__________________________________________________________Bettin N Boozin Logo by Erik Morgan (Instagram @erik_mgn10)__________________________________________________________Intro Music:Superepic by Alexander Nakarada | https://creatorchords.com/Music promoted by https://www.chosic.com/free-music/all/Attribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/...___________________________________________________________Horse Racing Intro Background Video graciously provided by @Fastec ImagingLink to video: www.youtube.com/watch?v=UfuI_TiKDYI&t=32s&pp=0gcJCR0AztywvtLA___________________________________________________________LINK TO A GREAT HORSE RACING OWNERSHIP OPPORTUNITY WITH CROWNS WAY RACING: https://sites.google.com/view/crowns-way-racing___________________________________________________________LINK TO SIGN UP TO BETUS -- (USE CODE RACING3H WHEN DEPOSITING MONEY)https://www.betus.com.pa___________________________________________________________#horseracing #BreedersCup #horseracingtips #HorseRacingStakes #gambling #sportsgambling #HorseRacingBets #KentuckyDerby #BelmontStakes #horseraces #gulfstreampark #GulfstreamPicks
Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast
Stereotype; Seriensuchten; Spoilerangst & die Sache mit dem blauen Himmel. Chris hat diesmal tatsächlich ein Thema mitgebracht. Sogar eins, das gleichzeitig banal, brisant und alltäglich ist: Stereotype. Warum wir sie brauchen, warum sie nerven und warum es so schwer ist, über sie zu sprechen, ohne sie größer zu machen.Doch bevor es philosophisch wird, streiten Alex & Chris erstmal darüber, ob die neue Serie Pluribus gespoilert werden darf, ob man Serien „staffelweise“ oder „wochenweise“ würdigt und warum Streamingdienste uns vielleicht doch nicht nur ärgern wollen. Und wer entscheidet eigentlich, wann eine Serie „kaputt optimiert“ wird?Dann geht's tief rein in die Psychologie: Warum unser Gehirn ohne Schemata komplett überfordert wäre. Wie Stereotype entstehen. Und weshalb es so verdammt schwer ist, negative Stereotype zu widerlegen, ohne sie beim Namen zu nennen. Chris ringt hörbar mit dem Thema, nicht nur wissenschaftlich, sondern emotional: Wie redet man über ungerechte Zuschreibungen, ohne sie versehentlich weiter zu füttern?Alex öffnet die große Meta-Schublade: In-Group versus Out-Group, warum Individuen plötzlich als „Ausnahme“ gelten, und wieso wir alle mit unzähligen unbemerkten Stereotypen herumlaufen. Manche harmlos („Germanisten vs. Linguisten“), andere gesellschaftlich hochproblematisch.Es geht um Wahrnehmung, Attribution, Frust, Verantwortung und um die Frage, wie wir als Gesellschaft wieder mehr echte Begegnung hinbekommen, die Stereotype langsam aufweichen kann.Zwischendurch: Preußische Vorfahren, Köln-Bergheim-Mythen, Baptisten, eine Moschee im Kölner Dom, Matheunterricht, schwarze Schwäne, der Kopf ist rund, damit man seine Meinung ändern kann, und der Moment, in dem ein harmloser Autofahrer plötzlich zur Projektionsfläche wird.Am Ende bleibt vielleicht keine endgültige Antwort, aber ein Gefühl dafür, warum diese Gespräche wichtig sind, selbst wenn sie sich manchmal im Kreis drehen.Viel Freude beim Hören und beim neugierigen Hinterfragen der eigenen Stereotypen. In der Folge erwähnt:Stereotyp: https://de.wikipedia.org/wiki/StereotypSerie Pluribus: https://de.wikipedia.org/wiki/Pluribus_%E2%80%93_Gl%C3%BCck_ist_ansteckendSerie Lost: https://de.wikipedia.org/wiki/Lost_(Fernsehserie)Serie Breaking Bad: https://de.wikipedia.org/wiki/Breaking_BadTerry Pratchett: https://de.wikipedia.org/wiki/Terry_Pratchett --------Noch ein Podcast:Perspektiven auf Software & Design von Chris & Alex.www.bessermit.design --------
The party meets the leader of Greengripe, who accuses them of banditry.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text
Subscribe to DTC Newsletter - https://dtcnews.link/signupWhen Sarah Carusona showed up to a DTC event last year, she didn't know it would spark her first client. That client's still with her. Today she runs BA Commerce, where her team drops into brands and drives growth from the inside.For DTC founders scaling from $5M to $20M who need strategy and execution in one package.What you'll learn:Why fractional CMOs often fall short and what brands really need insteadHow to drop in a trained operator who owns growth from top to bottomThe key metrics Sarah watches before touching a budget: contribution margin, AMER, LTV, and the “organic ratio”Why most influencer budgets are broken and what happens when you tie pay to performanceHow to focus your team's time when there's no room for fluffWho this is for:Founders and growth leads who are tired of hiring gaps, agency fluff, and shiny-object distractionsWhat to steal:Rebuild your org chart around execution, not job titlesStructure your influencer deals like paid media, not PRGet obsessed with contribution margin and work backward from thereTimestamps00:00 Why micro-iterations waste ad spend02:00 Sarah's global move and early consulting leap04:00 Building BA Commerce and the growth operator model09:00 How Sarah evaluates brands and sets growth metrics12:00 Creative fatigue, Andromeda, and persona-driven ads15:00 Creator partnerships and a tiered influencer program17:00 Why organic content still drives the biggest wins19:00 Modern Meta account structure and testing philosophy21:00 The biggest mistakes high-growth brands make23:00 Why product quality drives everything in growth25:00 Attribution, incrementality, and Sarah's forecasting model27:00 How Sarah uses AI and where she draws the lineHashtags#dtcpodcast #ecommerce #dtcbrands #mediabuying #growthmarketing #metaads #ugcads #influencermarketing #digitalstrategy #founderstories #shopifybrands #emailmarketing #smsmarketing #marketingpodcast #directtoconsumer Subscribe to DTC Newsletter - https://dtcnews.link/signupAdvertise on DTC - https://dtcnews.link/advertiseWork with Pilothouse - https://dtcnews.link/pilothouseFollow us on Instagram & Twitter - @dtcnewsletterWatch this interview on YouTube - https://dtcnews.link/video
Episode Notes Taxes were being collected which brought many people both single and married to this inn. Some couples with children. So the Father made sure that His Son would be identifiable without objection. Notice, they would never have thought to have looked for him in such a place as a manger in an animal stall. Our Outreach Web site is now closed. Sorry for any inconvenience. Introduction ~ About Us, Who We Are: Episode 1 How-To Be Saved: Episode 2 “End Times” and “Benediction” A “Barking Squirrel Production” Copyright: 2018 ~ All Rights Reserved Our Series: “Christmas 2025”: 2025-1201 Episode: 48 Copyright: 2025 TAGS: #Gospel #Christ #Newbirth #Joy #Holiness ---------------------------------------------- The following music was used for this media project: Music: Silent Night - Holy Night by Alexander Nakarada License (CC BY 4.0): https://filmmusic.io/standard-license Artist website: https://www.serpentsoundstudios.com/ Modified by: Pastor John Music: Jingle Jangle Bells by Snoozy Beats License (CC BY 4.0): licensed under a Attribution 4.0 International License. Allowed usage for Personal and commercial use. This music track (or part of it) was generated by A.I. The full track can be heard here: https://freemusicarchive.org/music/snoozy-beats/single/jingle-bells-kinda-day-10/ Edited by: Pastor John This podcast is powered by Pinecast.
Will Prime Minister Takaichi be a champion for women's rights?
"Working as an oncology infusion nurse, being oncology certified, attending chapter meetings, going to ONS Congress® has really taught me plenty. But being an oncology patient taught me way more. I know firsthand the fears 'you have cancer' brings. Then going through further testing, CT scans, MRIs, genetics, the whole preparation for surgery was something I never considered when I treated a breast cancer patient," ONS member Catherine Parsons, RN, OCN®, told Valerie Burger, MA, MS, RN, OCN®, CPN, member of the ONS 50th anniversary planning committee, during a conversation about her experience being an oncology nurse and cancer survivor. Burger spoke with Parsons and ONS members Margaret Hopkins, MSN, RN, OCN®, HNB-BC, and Afton Dickerson, MSN, AGACNP-BCP, CBCN®, AOCNP®, CGRA, about how cancer survivorship has shaped their careers as oncology nurses and personal lives. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: 50th anniversary series Episode 385: ONS 50th Anniversary: Evolution of Cancer Survivorship Episode 263: Oncology Nursing Storytelling: Renewal Episode 253: The Ethics of Caring for People You Know Personally Episode 187: The Critical Need for Well-Being and Resiliency and How to Practice Episode 91: The Seasons of Survivorship ONS Voice articles: Being a Patient Taught Me How to Be a Better Oncology Nurse by Margaret Hopkins Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession Our Unified Voices Can Improve Cancer Survivorship Care Why I Truly Understand How Our Patients Hold Onto Hope ONS book: Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum (third edition) ONS course: Essentials in Survivorship Care for the Advanced Practice Provider ONS Nurse Well-Being Learning Library ONS Huddle Cards: Coping Moral Resilience Survivorship Care Connie Henke Yarbro Oncology Nursing History Center To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Parsons: "I thought I knew cancer. I thought I knew the treatment. I thought I knew the side effects. There's so much I didn't know. There's so much behind the scenes before a patient comes and sits in my chair. The stuff that they go through I now can understand. It surprised me how much I didn't know." TS 11:39 Hopkins: "I had been thinking I'm going to be that hero, that I can go to work. I work at night, get 8 am radiation appointments, and go home and go to sleep and wake up and go to work again because everyone said, 'Oh, it's not that bad. Radiation will be okay. You can work.' … But the real challenge for me was I didn't know how to be a patient and a nurse at the same time. And my first radiation treatment, I go in there, and I change into the gown, and then I started cleaning up because I was getting treatment done at the hospital where I worked, and were taught if you see a mess, you clean it. So I was acting like a nurse. And I almost wanted to go help the other patients, but I couldn't because I had to focus on healing." TS 15:36 Dickerson: "What made the difference for me were the nurses who didn't just treat my illness. They treated me as a whole person—my emotions, my feelings. They made me smile. They would hold my hand or just take a moment to really ask, 'Hey, how are you?' And those small, little gestures made me feel worthy, made me feel like a human. I always tell nurses it's not just about the chemo; it's about the connection. Sometimes your presence is the most healing thing that you can offer to your patient." TS 30:52
A Record from The Library at the Center of Everything ep. 808 S. Labrecque is a fantasy author. She previously published "The Killer Doll and the Dollmaker," with Aphelion Webzine and two short stories that can be found on her website: https://slabrecqueauthor.com/ She writes a twice-monthly newsletter and posts on Instagram as she works on publishing her next novel. When she's not writing, Serena can be found hiking, cuddling her cats, and playing D&D with her family. ---- Listen Elsewhere ---- YouTube: https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you! ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords
In this episode of Wildlife by the Numbers, hosts Matt, Grant, and Randy explore methods for estimating wildlife abundance using both marked and unmarked techniques. They discuss distance sampling, removal sampling, N-mixture models, capture-mark-recapture, and spatial capture-recapture. The conversation emphasizes the importance of robust study design, detection probability, and population closure assumptions in ecological research.Episode Quotes“Marked simply means you have an animal like an ocelot that has spots… so you can identify the same individuals over time based on their coat pattern.”“Distance sampling is a technique in which you take advantage of the fact that things are harder to see or detect at greater distances… and use that to estimate abundance.”“Spatial capture-recapture incorporates where animals were observed and where traps were located… helping produce more precise estimates of abundance and spatial distribution.”Cite this episode: https://doi.org/10.7944/usfws.wbtn.s02ep01DOI Citation Formatter: https://citation.doi.org/Episode music: Shapeshifter by Mr Smith is licensed under an Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/https://freemusicarchive.org/music/mr-smith/studio-city/shapeshifter/
Today hosts Ema Sasic and Kevin Schwaller are diving into the world of Oscar nominations. They go through some of the top categories and decide who is in the running for the gold statue. Disclaimer:Copyright notice:(Intro/outro) She's The Greatest Dancer by Ryan Andersen is licensed under a Attribution-NonCommercial License. https://freemusicarchive.org/music/Ryan_Andersen/MORE/Shes_The_Greatest_Dancer?fbclid=IwAR1TDCO9eT6TxmDrTaJr9HRQVk2gUu00cNXeG8oik3avXVEhbSGqsqUfLkoCopyright notice:(Break) Extremely Tik-tok compatible for slow videos by Lundstroem is licensed under a Attribution 4.0 International License. https://freemusicarchive.org/music/lundstroem/the-happiest-songs/extremely-tik-tok-compatible-for-slow-videos/
What happens when AI, blockchain, and decentralized identity merge into a single system for human + machine knowledge? In this Grownlearn episode, host Zorina Dimitrova sits down with Billy Luedtke (ex-EY, ConsenSys, MetaMask) — now founder & CEO of Intuition Systems, the first blockchain network purpose-built for information finance. Billy breaks down: • Why decentralized information is the next frontier beyond DeFi • How Intuition's decentralized knowledge graph lets humans and AI trust the same data • Why tokenized information, decentralized search, and identity will reshape society • What lessons from Ethereum's early days shaped his vision • How Intuition gives users ownership & monetization rights over their data • Why centralized AI + search could lead to a dystopian future — and how we prevent it If you're building in Web3, AI, DeFi, decentralized identity, or data infrastructure, this episode gives a rare look into the architecture and philosophy behind one of the most ambitious projects in the Web3 space. ---------------------------------------------------------------------------------------------------------------------------------------------
In this episode we take a look at the all-new Gemini on my Google Nest Mini. We look at the quality of the Voices and the Trinity of Google Apps that seemingly are connected with the Nest of now, and more than likely the Nest of the Future!ATTRIBUTIONS Kyle Golden for his Audio Transition.Eleven Labs for Voices - 11.ai
They're not helpless babies Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast
In this episode, Brian and Josh discuss attribution theory and its impact on tennis performance. The co-hosts talk about how the interpretation of results makes a significant difference in how tennis players move on and grow from matches that they play. They reviewed the various factors that are included within attribution theory - whether a person attributes their results as internal/external, stable/unstable, and controllable/uncontrollable.To learn more about Josh and Brian's backgrounds and sport psychology businesses, go to TiebreakerPsych.com and PerformanceXtra.com. If you have feedback about the show or questions on the mental game in tennis you can email us at tennisiqpodcast@gmail.com. If you're enjoying the show please rate us on your favorite podcast platform including Apple Podcasts and Spotify and write a review. Don't forget to subscribe on YouTube or your podcast platform of choice (Apple Podcasts, Spotify, etc.) to stay up to date on future episodes.
The traditional linear shopping journey has collapsed. Commerce now happens everywhere, and consumers are navigating this omnimodal reality with unprecedented fluidity.Phillip Jackson and Lindsay Trinkle sit down with Melissa Minkow, Global Director of Retail Strategy and Insights at CI&T, to unpack findings from her Retail Tech Reality Check research. Together, they dissect how different platforms serve distinct purposes in the buyer's journey, why "omnichannel" is more relevant than ever, and what happens when everything becomes shoppable but commerce itself becomes invisible.In this episode, we explore how the expanded digital ecosystem is fundamentally reprogramming how consumers engage with content, community, and commerce. With 74% of US consumers now using AI tools in their path to purchase, brands can no longer control the narrative—instead, they must embed themselves intentionally into customer-led conversations across multiple contexts.Commerce Is Invisible; Context Isn'tKey takeaways:Each social platform serves a distinct purpose: Facebook for purchasing, YouTube for discovery, Reddit for research. Context matters more than channel ubiquity.The invisible transaction wins: TikTok succeeds because it's entertainment-first. The less commerce feels like commerce, the more consumers buy.Attribution is broken: Traditional linear models can't capture circular, contextual journeys. Focus on conversion, repeat purchase, and brand awareness—the only metrics you can trust.Search remains unsolved: Basic functionality like filtering furniture by dimensions is still missing. Data quality and search methodology are foundational competitive advantages.Micro-influencers drive outsized impact: 45 passionate referrals matter more than 45,000 followers. The persona of the referrer (picky, experimental, passionate) outweighs reach.AI will reshape holiday 2025: Gifting anxiety makes AI particularly valuable. Consumers use it to avoid looking stupid and navigate uncertain return processes.In-Show Mentions:Melissa Minkow - Global Director of Retail Strategy and Insights, CI&TCI&T Retail Tech Reality Check ResearchNew Modes ResearchAssociated Links:Check out Future Commerce on YouTubeCheck out Future Commerce+ for exclusive content and save on merch and printSubscribe to Insiders and The Senses to read more about what we are witnessing in the commerce worldListen to our other episodes of Future CommerceHave any questions or comments about the show? Let us know on futurecommerce.com, or reach out to us on Twitter, Facebook, Instagram, or LinkedIn. We love hearing from our listeners! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
After a last minute revelation, the party discards their previous plan in favor of another that is far riskier. Will this new approach prove successful, or are these teens walking right into three simultaneous traps? (for a list of content warnings, scroll to the bottom of the text) Featuring Claire Mulkerin, Jake Mason, Tanner Vogelgesang, Annie Craton, and Riley Hopkins. Edited by Claire Mulkerin. Logo by Ann McShane and Christina Woods. Our opening theme song is performed by Hashme Lloyd (soundcloud.com/whlsm), Samantha Bower (fiverr.com/amandapower), and Kylee Brielle (fiverr.com/kyleebrielle), and our closing theme is performed by Nice Wizard (soundcloud.com/nicewizard). "Nowhere Land" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/ Upbeat Energetic Uplifting Fun "Driftline".mp3 by Vlad Annenkov is licensed under a Attribution 4.0 International License. "Groovy Rock" by Lite Saturation is licensed under a CC BY-ND 4.0 International Deed. The game system we're using is Digidice, created by Claire Mulkerin. Find it at clairemulkerin.itch.io You can support Claire and join her Discord by becoming a member of the Claire Makes Art Patreon! https://www.patreon.com/clairemakesart Find us on Bluesky or Tumblr, where we are @BinaryBreak, or send an email to digimonbinarybreak@gmail.com Content Warning: Memory loss, body horror, mental illness, bullying, gun violence, insects with lots of legs
A collection of our conversations with others at the Great Lakes Paranormal Conference this past September. Interviews include owners of the Humbird Hotel Bar & Grill, Ghosts & Us, and 'friends of the show', Katie Skuban and Pat Haberman. The opening banter includes initial thoughts on the current happenings in the continuing saga of Morgan Geyser. Sit back and enjoy the conversations, here, on Episode 59 of Badger Bizarre, "The 3rd Annual Halloween (Thanksgiving..?) ParaShare." The Humbird Hotel Bar & Grill Ghosts and Us US Paranormal Research Please visit our sponsor: FrameMakers Facebook Twitter Website Email us: badgerbizarre@outlook.com Opening Trailer: Ed Gein Sound Byte : "Hard Copy" - Paramount Domestic/CBS Televsion Frank Lloyd Wright and Jeffery Dahmer Sound Byte - WISN 12 News - Milwaukee, WI Jeffery Dahmer Quotes: "Inside Edition" - King World/CBS Television/CBS Media Attribution for Music: Trailer: Composer: Adam Phillip Zwirchmayr https://www.pond5.com/ Intro: https://pixabay.com/ Outro: Composer: Viacheslav Sarancha https://www.pond5.com/ Attribution for logo design: Red Claw Scratch Photo
Cheers to the Host ep. 807 Over eighty-five of Laura Campbell's short stories have appeared in Chilling Crime Stories, Road Kill: Texas Horror by Texas Writers Vol. 6, Reader Beware: A Fear Street Appreciation Anthology, and other publications. Most of Laura's recent works are available on Amazon. Laura's short stories "From the Garden" and "416175" can be heard on Spotify's 'Scare You to Sleep' podcast. When she is not writing, Laura can be found running alongside Houston's bayous or attending live music performances. She is encouraged in her writing by her children, Alexander and Samantha. ---- Listen Elsewhere ---- YouTube: https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you! ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords
In dieser Folge sprechen wir mit Pius Sprenger (Pius the Banker) über seine Zeit an der Wall Street und darüber, wie er schließlich zu Bitcoin gefunden hat. Wir tauchen ein in den Alltag im Banking, hören, welche Ereignisse ihn besonders geprägt haben, und diskutieren, ob sich Bitcoin nach der Finanzkrise regelrecht „aufgedrängt“ hat. Außerdem sprechen wir darüber, ob Bitcoin mehr ist als nur sein Preis, ob das Thema inzwischen bei Bankern und wirtschaftlichen Eliten angekommen ist – und wie man sich Bitcoin generell öffnen kann.
Episode Notes Jesus being born of human form of a virgin, it is in this act, the good will and amazing love of God, to man is displayed. That alone is miraculous! That alone should excite good tidings that were then and are now, both wonderful and amazing. In other words, this was good news and glad tidings. Our Outreach Web site, https://thechurchoftheunchurched.org/ is now closed. Sorry for any inconvenience. Introduction ~ About Us, Who We Are: Episode 1 How-To Be Saved: Episode 2 “End Times” and “Benediction” A “Barking Squirrel Production” Copyright: 2018 ~ All Rights Reserved Our Series: “Christmas 2025”: 2025-1105 Episode: 47 Copyright: 2025 TAGS: #Gospel #Christ #Newbirth #Joy #Holiness ---------------------------------------------- The following music was used for this media project: Music: Silent Night - Holy Night by Alexander Nakarada License (CC BY 4.0): https://filmmusic.io/standard-license Artist website: https://www.serpentsoundstudios.com/ Modified by: Pastor John Music: Jingle Jangle Bells by Snoozy Beats License (CC BY 4.0): licensed under a Attribution 4.0 International License. Allowed usage for Personal and commercial use. This music track (or part of it) was generated by A.I. The full track can be heard here: https://freemusicarchive.org/music/snoozy-beats/single/jingle-jangle-christmas Modified by: Pastor John This podcast is powered by Pinecast.
"Antibody–drug conjugates (ADCs) have three basic parts: the antibody part, the cytotoxic chemo, and the linker that connects the two. First, the antibody part binds to the target on the surface of the cell. Antibodies can be designed to bind to proteins with a very high level of specificity. That's what gives it the targeted portion. Then the whole thing gets taken up by the cell and broken down, which releases the chemotherapy part. Some sources will call this the 'payload' or the 'warhead.' That's the part that's attached to the 'heat-seeking' part, and that's what causes the cell death," Kenneth Tham, PharmD, BCOP, clinical pharmacist in general oncology at the University of Washington Medicine and Fred Hutchinson Cancer Center in Seattle, WA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about antibody–drug conjugates. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 28, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the mechanism of action of antibody–drug conjugates. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 303: Cancer Symptom Management Basics: Ocular Toxicities Episode 283: Desensitization Strategies to Reintroduce Treatment After an Infusion-Related Reaction ONS Voice articles: An Oncology Nurse's Guide to Cancer-Related Ocular Toxicities Antibody–Drug Conjugates Join the Best of Two Worlds Into One New Treatment Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer Oncology Nurses' Role in Translating Biomarker Testing Results The Pharmacist's Role in Combination Cancer Treatments ONS Voice drug reference sheets: Belantamab mafodotin-blmf Datopotamab deruxtecan-dlnk Enfortumab vedotin Fam-trastuzumab deruxtecan-nxki ONS book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) ONS course: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ Clinical Journal of Oncology Nursing articles: Antibody–Drug Conjugates and Ocular Toxicity: Nursing, Patient, and Organizational Implications for Care Nurse-Led Grading of Antineoplastic Infusion-Related Reactions: A Call to Action Other ONS resources: Antineoplastic Administration Huddle Card Biomarker Database Chemotherapy Huddle Card Monoclonal Antibodies Huddle Card Association of Cancer Care Centers (ACCC) antibody–drug conjugates page Drugs@FDA Hematology/Oncology Pharmacy Association (HOPA) National Cancer Institute cancer drugs page Network for Collaborative Oncology Development and Advancement (NCODA) clinical resource library ACCC/HOPA/NCODA/ONS Patient Education Sheets website To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "The mechanism of action of the chemo itself depends on what agent or what 'warhead' is attached. Generally, [ADCs] have some kind of cytotoxic mechanism related to many of the chemotherapies that we use in practice, without attachment to the antibody. Some of them can be microtubule inhibitors, vinca alkaloids like vincristine. Some of them can be topoisomerase I (TOP1) inhibitors like irinotecan. Some can be alkylating agents that cause DNA breaks. So, again, looking back at the arsenal we have of cytotoxic chemo, these can all be incorporated into the ADCs." TS 5:54 "I want to talk about a case where the biomarker is being tested, but the biomarker isn't the target that you're looking for. One good case of this is a newer agent that was approved called datopotamab deruxtecan. The datopotamab portion is specific to a target called 'trophoblast cell surface antigen 2' (TROP2), which is expressed on the surface of many epithelial cancers. This agent was first approved in hormone receptor-positive, HER2-negative breast cancer, and received accelerated approval in patients with non-small cell lung cancer (NSCLC) with an EGFR mutation. ... The antibody looks for a target, TROP2. But in both of these cases—in the breast cancer and the NSCLC—you're testing for expression of different mutations or lack thereof. You're not looking for expression of TROP2. There's more research that needs to be done about the relationship between TROP2 expression and the presence or absence of these other biomarkers, but until we know more, we're actually testing for biomarkers that aren't the target of the ADC." TS 10:22 "There are common adverse advents to antibodies and chemo in general. Because we have both of these components, we want to watch out for the adverse effects of both of them. Antibodies, as with most proteins, can trigger an immune response or an infusion reaction. So, many ADCs can also cause hypersensitivity or infusion reactions. The rates of that are really variable and depend on the actual antibodies themselves. Then you have the cytotoxic component, the chemotherapy component, which has its own characteristic side effects. So, if we think of general chemo side effects—fatigue, nausea, bone marrow suppression, alopecia—these can [occur] with a lot of ADCs as well." TS 15:34 "The rate of ocular toxicity in [mirvetuximab soravtansine] is quite high. The manufacturer reports that this can occur in up to 60% of patients. With rates so high, the manufacturer recommends a preventive strategy. For this particular agent, [they] recommend patients have required eyecare. ... This ocular toxicity is something we do see in other ADCs that don't have the same target and don't necessarily have the same payload component. For example, tisotumab vedotin and again, datopotamab deruxtecan, can both cause ocular toxicities and both would have required ocular supportive care." TS 20:08 "Overall, I feel like the future is incredibly bright for these agents. There have only been around a dozen therapies approved by the U.S. Food and Drug Administration (FDA) despite this idea—the first agent came out in 2000. So, 25 years later, there are only around a dozen FDA-approved treatments. But there are so many more that are coming through the pipeline. And as we're discovering more biomarkers and developing more specialized antibodies, it's only natural that more ADCs will follow." TS 26:50
Today, we get to learn from Matthew Paneitz, founder and executive director of Long Way Home. This organization built Hero School, a student-built and community-built campus in San Juan Comalapa, Guatemala.Built from recycled tires and trash, the campus took 16 years to build and serves 178 students enrolled in PreK through High School. The school campus is almost complete.Matthew is also the recipient of the 2020 Sargent Shriver Award for Distinguished Humanitarian Service for his work in Guatemala. This award, presented annually by the National Peace Corps Association, honors Peace Corps volunteers who continue to contribute to humanitarian causes.Long before this award and the existence of Hero School, Matthew had an idea.An idea that needed funding, direction, and partners.How did Matthew obtain funding when he started this project?How did he develop a strategy sustaining him and the school he built with the residents of Comalapa?What is the school's curriculum, and how does it change the conversation around poverty?Let's find out. LINKSLong Way Home - Turn Trash Into SchoolsLong Way Home Sustainability Projects (https://www.lwhomegreen.org)Help School Fight Climate Change with Green Building (Global Giving) - Giving Tuesday is December 2, 2025Watch timelapse video of recent classroom construction (Fall 2025)2020 Sargent Shriver Award for Distinguished Humanitarian ServiceEcoHab.orgLong Way Home on YouTubeLong Way Home on FacebookLong Way Home on InstagramLong Way Home on LinkedIn _______________CREDITS:Producer: Tania MarienMusic: So Far So Close by Jahzzar is licensed under a Attribution-ShareAlike License;SOLO ACOUSTIC GUITAR by Jason Shaw is licensed under a Attribution 3.0 United States License.Subscribe to Transferable Solutions, a newsletter about reimagining environmental skillsContact Us© 2019 - 2025 Talaterra Inc ABOUT:TALATERRA combines "tala" (Icelandic for "to speak" and "to talk") with "terra" (Earth)—because speaking for our planet and telling its stories is what environmental educators do.TALATERRA: to speak Earth. * TALATERRA is an affiliate of Bookshop.org.
In Old Saybrook, CT on December 16, 1957, between the hours of 2 and 3 A.M., a local teacher witnessed something incredible: outside her window, Mary M. Starr saw a spaceship with aliens inside. Her encounter was not the first. Leaving behind a trail of mysteries and murders, the Case of the Saybrook Blockheads is one of fear, greed, and secrecy.CREDITSAtomic Snapshots of Shared Memory.mp3 by Geoff Keston is licensed under a Attribution 4.0 International License.Zinc by CXR ATK is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.Manoeuvre by CXR ATK is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License. Land-escape by Safir Nou is licensed under a Attribution-NonCommercial-NoDerivatives 4.0 International License. отдушинка by Kosta T is licensed under a CC0 1.0 Universal License. SOURCEShttps://www.ufoinsight.com/aliens/encounters/alien-encounters-mary-starr-suzanne-knighthttps://bogleech.com/realalienshttps://cryptidz.fandom.com/wiki/Old_Saybrook_BlockheadsSend the BCWPA a message!Support the showDo you have information, feedback, or a question? Submit a report.Grab a cryptid study, visit the Ballyraven store.
The party travels to Greengripe, where they learn about goblin pickling.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text
Prof. Silverman describes the first Thanksgiving: an accidental feast between frenemies that was never repeated. How much is our Thanksgiving tradition based on real events that transpired sometime in the fall of 1621 in Plymouth, Massachusetts? And why does it matter anyway?Don't all nations have feel-good traditions that are partly based on facts, but mostly predicated on myths? Professor David Silverman answers these questions and more. For example, he shares with us that Europeans had been in contact with the Wampanoag Native Americans, who are the "Indians" of our Thanksgiving tradition, since at least 1524. And that the Pilgrims were guided to Plymouth by at least one crew member who touted its advantage - hint: all its native inhabitants had died of disease, leaving houses and fields empty and available for the would-be English settlers. And while the turkey was certainly on the menu, so was eel! In this episode, Professor Silvermans explains the aftermath of that first Thanksgiving. And by way of follow-up, I ask him to explain why it is that some Native Americans observe a Day of Mourning on Thanksgiving. Professor Silverman is the author of This Land is Their Land: The Wampanoag Indians, Plymouth Colony, and the Troubled History of Thanksgiving, a 2019 book. Click this link for this book's Amazon page. Professor Silverman has written several other books about the history of Native Americans, which are listed on his academic homepage is along with his other publications, projects and honors. Here is the direct link to Professor Silverman's academic homepage: https://history.columbian.gwu.edu/david-silverman History of Christmas: In this interview, Dr. Carey Roberts tells us the real story behind America's celebration of Christmas. I hope you enjoy this episode. Adel, host & producerHistory Behind News podcast & on YouTube►SUPPORT: Click here and join our other supporters in the news peeler community. Thank you.
"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16
Requiem ep. 806 Roger Ley has self-published eight novels and one anthology of speculative stories. He was born and educated mainly in London, but spent some of his formative years in Saudi Arabia. Later, he worked as an engineer in the oilfields of North Africa and in the North Sea before starting a career in higher education teaching computer-aided engineering. His early articles appeared in publications including The Guardian, Reader's Digest, The Oldie, and Best of British. His short stories have been published on a multiplicity of websites. He lives in Suffolk (UK). Visit his website at rogerley.co.uk More TTV Stories by Roger ley: https://talltaletv.com/tag/roger-ley/ ---- Listen Elsewhere ---- YouTube: https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you! ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords
We're back with the very liberated Susan Scott and her beau Luciano Ercoli, along with a host of giallo regulars, for Ercoli's first giallo The Forbidden Photos of a Lady Above Suspicion/Le foto proibite di una signora per bene, from 1970. CW: Violence, gendered violence, sexual assault. Copyright © 2025 David Thomas and Jon Dear Availability on disc and streaming: Blu-ray.com Our theme music:Silent Night (Dark Piano Version) by myuu Creative Commons — Attribution 3.0 Unported— CC BY 3.0Free Download/Stream Music promoted by Audio Library Giallo Reading ListLa Dolce Morte: Vernacular Cinema and the Italian Giallo Film by Mikel J. Koven Italian Giallo in Film and Television: A Critical History by Roberto Curti So Deadly, So Perverse: 50 Years of Italian Giallo Films by Troy HowarthVolume 1: 1963-1973Volume 2: 1974-2013Volume 3: Giallo-Style Films From Around the World Mario Bava: All the Colours of the Dark by Tim Lucas Dario Argento: The Man, the Myths & the Magic by Alan Jones All the Colours of Sergio Martino by Kat Ellinger Beyond Terror: The Films of Lucio Fulci by Stephen Thrower Human Beasts: The Films of Paul Naschy by Troy Howarth Make Them Die Slowly: The Kinetic Cinema of Umberto Lenzi by Troy Howarth
Hosts Kevin Schwaller and Ema Sasic follow the Yellow Brick Road back to Oz for "Wicked: For Good," the sequel to last year's blockbuster musical "Wicked" starring Cynthia Erivo, Ariana Grande, Jonathan Bailey, Ethan Slater, Marissa Bode, Michelle Yeoh and Jeff Goldblum! Have they been changed for good? Were there bridges they crossed they didn't know they crossed until they crossed? Is there no good deed that they'll do again?Disclaimer:Copyright notice:(Intro/outro) She's The Greatest Dancer by Ryan Andersen is licensed under a Attribution-NonCommercial License. https://freemusicarchive.org/music/Ryan_Andersen/MORE/Shes_The_Greatest_Dancer?fbclid=IwAR1TDCO9eT6TxmDrTaJr9HRQVk2gUu00cNXeG8oik3avXVEhbSGqsqUfLkoCopyright notice:(Break) Extremely Tik-tok compatible for slow videos by Lundstroem is licensed under a Attribution 4.0 International License. https://freemusicarchive.org/music/lundstroem/the-happiest-songs/extremely-tik-tok-compatible-for-slow-videos/
Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast
The party hits a major breakthrough in its investigation of the bloom.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text
Text us your thoughts on the episode or the show!In this episode of OpsCast, hosted by Michael Hartmann and powered by MarketingOps.com, we are joined by Penny Hill, Founder and Principal Consultant at Three Threads Consulting. Penny has built her career at the intersection of marketing, operations, and strategy, helping teams simplify complexity, connect departments, and make data more meaningful.The conversation centers on one of the most common sources of friction in go-to-market teams: attribution and alignment. Penny shares insights on why teams often clash over credit, what “marketing contribution” truly means, and how simplifying metrics and conversations can drive stronger collaboration and better outcomes.In this episode, you will learn:Why attribution continues to challenge marketing and sales alignmentHow to simplify performance measurement without losing insightWays to present metrics that build trust with executives and peersHow Marketing Ops professionals can shift the focus from “who gets credit” to “how we win together”This episode is perfect for Marketing Ops, RevOps, and go-to-market professionals who want to improve collaboration, clarity, and trust across their organizations.Episode Brought to You By MO Pros The #1 Community for Marketing Operations Professionals Ops Cast is brought to you in partnership with Emmie Co, an incredible group of consultants leading the top brands in all things Marketing Operations. Check the mount at Emmieco.comSupport the show
"It's critical to identify those mutations found that are driving the cancer's growth and guide the personalized treatment based on those results. And important to remember, too, early testing is crucial for patients with non-small cell lung cancer (NSCLC). In studies, it has been found to be associated with improved survival outcomes and reduced mortality," ONS member Vicki Doctor, MS, BSN, BSW, RN, OCN®, precision medicine director at the City of Hope Atlanta, GA, Chicago, IL, and Phoenix, AZ, locations, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the oncology nurse's role in NSCLC biomarker testing. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 This podcast is sponsored by Lilly Oncology and is not eligible for NCPD contact hours. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Episode Notes This episode is not eligible for NCPD. ONS Podcast™ episodes: Episode 363: Lung Cancer Treatment Considerations for Nurses Episode 359: Lung Cancer Screening, Early Detection, and Disparities Episode 238: Cancer Genomics for Every Oncology Nurse Episode 157: Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Only a Third of Patients With Advanced Cancer Get Biomarker Testing, Limiting Use of Potentially Effective Precision Therapies Precision Medicine in Lung Cancer: How Comprehensive Testing Optimizes Patient Outcomes Targeted Therapies Are Transforming the Treatment of Non-Small Cell Lung Cancer ONS book: Guide to Cancer Immunotherapy (second edition) ONS course: Genomic Foundations for Precision Oncology Clinical Journal of Oncology Nursing article: Using Nurse Navigators to Improve Timeliness of Biomarker Testing for Non-Small Cell Lung Cancer Oncology Nursing Forum article: Precision Medicine Testing and Disparities in Health Care for Individuals With Non-Small Cell Lung Cancer: A Narrative Review Other ONS resources: Best Practices for Biomarker Testing in Non-Small Cell Lung Cancer: A Case Study Genomics and Precision Oncology Learning Library Genomics Case Study: Precision Medicine in the Setting of Metastatic Non-Small Cell Lung Cancer Biomarker Database (refine by non-small cell lung cancer) Genomic Biomarkers Huddle Card Targeted Therapy Huddle Card National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "These biomarkers are used to provide information about cancer's characteristics or behavior. In oncology precision medicine specifically, molecular tests can help with diagnosing a cancer that is maybe an unknown primary. It can help with monitoring response to therapy, detect recurrence of disease before other tests can find that, predict prognosis or how aggressive the cancer may be, and guide treatment decisions for targeted therapies." TS 3:14 "Some of the key biomarkers recommended by the National Comprehensive Cancer Network (NCCN) to be tested in patients who have NSCLC are EGFR, ALK, KRAS, BRAF, MET exon 14 skipping mutation, HER2 which is a protein expression from an ErbB protein, PD-L1 which is a protein expression that's used to guide immunotherapy choices, and then finally there are three fusions: ROS1, RET, and NTRK. [These] are pretty rare but really important to be tested for in patients who have NSCLC." TS 3:46 "Another important challenge for nurses related to this topic is that these results may not reveal a targeted mutation for the patient and that could be very disappointing. So, being able to provide that emotional support to a patient if they have that result … you can actually reinforce with them that if [they] go onto another treatment that the physician decides to put [them] on, the tumor can change. New pathogenic variants can develop based on the treatment that they're getting, and another test can be done. And maybe at that time—a new biomarker that could be targeted—we'd be seeing on the new test." TS 7:32 "Another circumstance we didn't talk about yet is that maybe the result came back saying that the quality was not sufficient. And sometimes that happens, but that doesn't mean that we're at the end of the road, necessarily. So, you could explain to the patient that that may mean that possibly, a new biopsy would be ordered by the physician. Or if a new biopsy or another tissue sample is not available, then maybe the physician would pivot to sending a blood specimen for the molecular testing. So that would definitely be a way [nurses] could support their patients." TS 11:52 "In the case of patients with NSCLC, early testing is so important. So, advocating for that prompt biomarker testing to be done, making sure that it's comprehensive, that it's actually looking for all of those—I think it was 12 biomarkers—that I mentioned earlier. That this testing is done as soon as possible after diagnosis or progression. Something that I talk about all the time—personalized care, precision medicine—really matters. So, tailoring treatments for patients based on the biology of the tumor that's driving the cancer's growth is really crucial if you're going to be working as an oncology nurse. Another crucial thing, because it's changing so quickly, is to stay informed." TS 16:23
Course Correction ep.805 M.R. Lehman Wiens is a Pushcart-nominated writer and stay-at-home dad living in Minnesota. His work has previously appeared, or is upcoming in, F(r)iction, Short Édition, Consequence, The Wild Umbrella Literary Journal, and others. He can be found at lehmanwienswrites.com. Course Correction previously appeared in the Fall 2019 issue of The First Line Literary Journal ---- Listen Elsewhere ---- YouTube: https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you! ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords
How Gerrymandering has backfired on its proponents.
This is 22 Hours: A Second Look, where we revisit our original season with host Megan Cloherty. In this episode, you'll hear what happened when Megan reached out to Daron Wint in prison. You'll learn just how many prisons he's been transferred to in the last 10 years, why he filed suit while he was inside, and what it takes to communicate with a prisoner in a federal penitentiary.New episodes drop every Tuesday.Original Episode-After Daron Wint's conviction, federal prosecutors press the judge for the harshest possible sentence and, for the first time reveal his history of explosive rage, violent threats and assaults. At Daron's sentencing, emotional statements from the two surviving Savopoulos daughters are read in court. As the last regular episode comes to a close, we reflect back.This episode is written and produced by reporters Megan Cloherty and Jack Moore. Julia Ziegler is the content adviser. "22 Hours: An American Nightmare" is a production of WTOP News in Washington, D.C. All music featured in "22 Hours: An American Nightmare" is licensed through Creative Commons and/or by permission of the artist. We're grateful to all the artists whose music has helped us tell this story. Music for this episode is “Haters Hate” by Ramone Messam; “Beyond the Lows” by The Whole Other and “Spookster” by Wayne Jones, available in the YouTube Audio Library. “Rhythmic Pulse” and “Closing my Eyes for a Moment” by Daniel Birch and “Harbor” by Kai Engel are licensed under Creative Commons by Attribution 4.0 International.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
This is 22 Hours: A Second Look, where we revisit our original season with host Megan Cloherty. In this episode, Megan is joined once again by Abigail Savopoulos. Abigal shares stories about her brother Philip, like how he got into racing and anecdotes about her little brother's BIG personality. She also speaks candidly about losing him, and how she managed to get through the trial while in college.New episodes drop every Tuesday.Original Episode-After six weeks, dozens of witnesses and hours of testimony, emotions were running high when attorneys delivered their closing arguments. Then the United States v. Daron Wint went to the jury. Some of the men and women who decided Daron Wint's fate take us inside the deliberation room as they weighed the evidence and came to a conclusion. This episode is written and produced by reporters Megan Cloherty and Jack Moore. Julia Ziegler is the content adviser. MUSIC: All music featured in "22 Hours: An American Nightmare" is licensed through Creative Commons and/or by permission of the artist. We're grateful to all the artists whose music has helped us tell this story. "Haters Hate" by Ramone Messam, used with permission of the artist; "Rhythmic Pulse” by Daniel Birch and “Weirder” by Drake Stafford, licensed under Creative Commons by Attribution 4.0 International; and "Cast of Pods" by Doug Maxwell and “A Great Darkness Approaches, Can You Feel It” by ELPHNT, available in the YouTube Audio Library.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.